Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laia Vilà Martinez"'
Autor:
Juan Jose Garcia, Maria de los Llanos Gil, Eudald Felip, Iris Teruel, Laia Vilà Martinez, Mireia Margeli, Clara Lezcano, Max Hardy, Vanesa Quiroga, Beatriz Cirauqui
Publikováno v:
Journal of Clinical Oncology. 34:e17564-e17564
e17564Background: Neutrophil/lymphocyte (NLR) and lymphocyte/monocyte ratio (LMR) have been described as prognostic factors in cancer. Lymphoepithelioma is a type of poorly differentiated nasophary...
Autor:
Max Hardy, Clara Lezcano, Niki Karachaliou, Rafael Rosell, Patricia Cuadras, Laia Vilà Martinez, Belen Sanchez, Jose Luis Ramirez, Maria de los Llanos Gil, Carlos Pollan, Mireia Margeli, Imane Chaib, Ana Munoz, Beatriz Cirauqui, Ana Drozdowskyj, Vanesa Quiroga, Isabel Planas, Juan Verges, Ana Massuet, Ariadna Quer
Publikováno v:
Journal of Clinical Oncology. 33:e17025-e17025
e17025 Background: Platinum-based CRT is preferred standard of care for locally advanced HNC. However, survival benefit is small, with substantial toxicity and biomarkers of CRT resistance could gu...
Autor:
Aram Boada, Alberto Indacochea, Sebastián Morán, Maria de los Llanos Gil, Max Hardy, Eva Martinez-Balibrea, Anna Martinez Cardús, Cristina Buges, Iris Teruel, Manel Esteller, Jose Luis Cuadra-Urteaga, Jose Luis Manzano, Laura Layos, Laia Vilà Martinez, María Teresa Fernández-Figueras
Publikováno v:
ResearcherID
e20059 Background: The treatment of MM has evolved over the last four years to include novel treatments in addition to CT, requiring predictive markers of response. Treatment with BMI provides bene...
Autor:
Cristina Carrato, Carmen Balana, Anna Estival, Olatz Etxaniz, Jose Luis Ramirez, Pilar Teixidor, Laia Vilà Martinez, Rocio Diaz, Alberto Indacochea, Sara Ahlal, Itziar de Aguirre, Cristina Queralt, Ana Munoz, Salvador Villà, Rafael Rosell
Publikováno v:
Journal of Clinical Oncology. 33:2046-2046
2046 Background: Current therapy of LGG is based on clinical, radiologic and histologic ( Pignatti prognostic classification ) features .In the last years genomic profile of LGG has been investigat...
Autor:
Eva Castellà, Yessica Lopez, Itziar de Aguirre, Cristina Queralt, Laia Vilà Martinez, Maria de los Llanos Gil Gil Moreno, Mireia Margeli, Jose Luis Mate, Jose Luis Ramirez, Jose Luis Cuadra Urteaga, Alberto Indacochea, Enric Carcereny Costa, Teresa Moran, Rafael Rosell, Vanesa Quiroga, Beatriz Cirauqui
Publikováno v:
Journal of Clinical Oncology. 33:e19112-e19112
e19112 Background: EGFR-m in NSCLC and its responsiveness to TKI has proved beneficial in a subset of NSCLC patients (p) Breast cancer (BC) represents the most incident neoplasm among women. The co...
Autor:
Jose Luis Cuadra-Urteaga, Cristina Buges, Vanesa Quiroga, Laia Vilà Martinez, Rafael Rosell, Yolanda Luis, Eli Nancy Perez, Laia Capdevila, Beatriz Gutierrez, Iris Teruel, Sara Cros, Anna Estival, Teresa Moran, Alberto Indacochea, Sara Ahlal, Josep Jové, Enric Carcereny Costa, N. Pardo, Max Hardy-Werbin, Maria de los Llanos Gil Gil Moreno
Publikováno v:
Journal of Clinical Oncology. 33:e22139-e22139
e22139 Background: During the last years, new predictive and less frequent biomarkers have emerged in NSCLC, such as ROS1 translocation (ROS1t), HER2 mutations (HER2m) and BRAF mutations (BRAFm). W...